APNHY
Price
$6.57
Change
-$0.02 (-0.30%)
Updated
May 16 closing price
Capitalization
4.83B
TEVA
Price
$16.95
Change
+$0.07 (+0.41%)
Updated
May 16, 04:59 PM (EDT)
Capitalization
15.06B
81 days until earnings call
Ad is loading...

APNHY vs TEVA

Header iconAPNHY vs TEVA Comparison
Open Charts APNHY vs TEVABanner chart's image
Aspen Pharmacare Holdings
Price$6.57
Change-$0.02 (-0.30%)
Volume$553
Capitalization4.83B
Teva Pharmaceutical Industries
Price$16.95
Change+$0.07 (+0.41%)
Volume$77.78K
Capitalization15.06B
APNHY vs TEVA Comparison Chart
Loading...
TEVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APNHY vs. TEVA commentary
May 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APNHY is a Hold and TEVA is a Hold.

Ad is loading...
COMPARISON
Comparison
May 17, 2025
Stock price -- (APNHY: $6.59 vs. TEVA: $16.87)
Brand notoriety: APNHY: Not notable vs. TEVA: Notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: APNHY: 37% vs. TEVA: 74%
Market capitalization -- APNHY: $4.83B vs. TEVA: $15.06B
APNHY [@Pharmaceuticals: Other] is valued at $4.83B. TEVA’s [@Pharmaceuticals: Other] market capitalization is $15.06B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APNHY’s FA Score shows that 1 FA rating(s) are green whileTEVA’s FA Score has 1 green FA rating(s).

  • APNHY’s FA Score: 1 green, 4 red.
  • TEVA’s FA Score: 1 green, 4 red.
According to our system of comparison, TEVA is a better buy in the long-term than APNHY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TEVA’s TA Score shows that 6 TA indicator(s) are bullish.

  • TEVA’s TA Score: 6 bullish, 4 bearish.

Price Growth

APNHY (@Pharmaceuticals: Other) experienced а +2.01% price change this week, while TEVA (@Pharmaceuticals: Other) price change was -6.64% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.72%. For the same industry, the average monthly price growth was +12.60%, and the average quarterly price growth was +27.89%.

Reported Earning Dates

APNHY is expected to report earnings on Mar 03, 2025.

TEVA is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.72% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TEVA($15.1B) has a higher market cap than APNHY($4.83B). TEVA has higher P/E ratio than APNHY: TEVA (22.62) vs APNHY (14.73). APNHY YTD gains are higher at: -20.218 vs. TEVA (-23.457). APNHY has higher annual earnings (EBITDA): 7.98B vs. TEVA (1.56B). APNHY has more cash in the bank: 8.05B vs. TEVA (3.23B). TEVA has less debt than APNHY: TEVA (20.2B) vs APNHY (26.8B). APNHY has higher revenues than TEVA: APNHY (38.4B) vs TEVA (15.8B).
APNHYTEVAAPNHY / TEVA
Capitalization4.83B15.1B32%
EBITDA7.98B1.56B512%
Gain YTD-20.218-23.45786%
P/E Ratio14.7322.6265%
Revenue38.4B15.8B243%
Total Cash8.05B3.23B249%
Total Debt26.8B20.2B133%
FUNDAMENTALS RATINGS
APNHY vs TEVA: Fundamental Ratings
APNHY
TEVA
OUTLOOK RATING
1..100
6320
VALUATION
overvalued / fair valued / undervalued
1..100
12
Undervalued
71
Overvalued
PROFIT vs RISK RATING
1..100
8553
SMR RATING
1..100
10095
PRICE GROWTH RATING
1..100
8644
P/E GROWTH RATING
1..100
9213
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

APNHY's Valuation (12) in the null industry is somewhat better than the same rating for TEVA (71) in the Pharmaceuticals Generic industry. This means that APNHY’s stock grew somewhat faster than TEVA’s over the last 12 months.

TEVA's Profit vs Risk Rating (53) in the Pharmaceuticals Generic industry is in the same range as APNHY (85) in the null industry. This means that TEVA’s stock grew similarly to APNHY’s over the last 12 months.

TEVA's SMR Rating (95) in the Pharmaceuticals Generic industry is in the same range as APNHY (100) in the null industry. This means that TEVA’s stock grew similarly to APNHY’s over the last 12 months.

TEVA's Price Growth Rating (44) in the Pharmaceuticals Generic industry is somewhat better than the same rating for APNHY (86) in the null industry. This means that TEVA’s stock grew somewhat faster than APNHY’s over the last 12 months.

TEVA's P/E Growth Rating (13) in the Pharmaceuticals Generic industry is significantly better than the same rating for APNHY (92) in the null industry. This means that TEVA’s stock grew significantly faster than APNHY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TEVA
RSI
ODDS (%)
Bearish Trend 2 days ago
59%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
65%
Momentum
ODDS (%)
Bullish Trend 2 days ago
73%
MACD
ODDS (%)
Bullish Trend 2 days ago
63%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
67%
Advances
ODDS (%)
Bullish Trend 9 days ago
70%
Declines
ODDS (%)
Bearish Trend 2 days ago
74%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
74%
Aroon
ODDS (%)
Bullish Trend 2 days ago
69%
View a ticker or compare two or three
Ad is loading...
TEVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY590.462.87
+0.49%
SPDR® S&P 500® ETF
BTC.X103744.640000205.226560
+0.20%
Bitcoin cryptocurrency
GME28.63-0.10
-0.35%
GameStop Corp
AAPL211.45-0.88
-0.41%
Apple
TSLA342.82-4.86
-1.40%
Tesla

APNHY and

Correlation & Price change

A.I.dvisor tells us that APNHY and TEVA have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that APNHY and TEVA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APNHY
1D Price
Change %
APNHY100%
-3.94%
TEVA - APNHY
23%
Poorly correlated
-0.12%
PRFX - APNHY
18%
Poorly correlated
-3.06%
QNTM - APNHY
17%
Poorly correlated
+11.31%
ALID - APNHY
7%
Poorly correlated
+11.54%
YCBD - APNHY
0%
Poorly correlated
+1.02%
More

TEVA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TEVA has been loosely correlated with AMRX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if TEVA jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TEVA
1D Price
Change %
TEVA100%
-0.12%
AMRX - TEVA
38%
Loosely correlated
+2.04%
VTRS - TEVA
26%
Poorly correlated
+4.39%
ELAN - TEVA
26%
Poorly correlated
+0.47%
TLRY - TEVA
26%
Poorly correlated
-0.32%
BHC - TEVA
26%
Poorly correlated
+0.88%
More